FORA Capital’s Boston Scientific BSX Stock Holding History

FORA Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.3M	Buy	370,934 +359,135	+3,044%	+$28.7M	1.71%	1
2025 Q4	$919K	Buy	+11,799	New	+$1.16M	0.11%	214
2025 Q3	–	Sell	-3,133	Closed	-$337K	–	500
2025 Q2	$337K	Sell	3,133 -47,850	-94%	-$4.84M	0.04%	389
2025 Q1	$5.14M	Buy	+50,983	New	+$5.13M	0.52%	50
2022 Q4	–	Sell	-18,778	Closed	-$727K	–	478
2022 Q3	$727K	Buy	+18,778	New	+$753K	0.14%	201
2020 Q2	–	Sell	-34,237	Closed	-$1.12M	–	920
2020 Q1	$1.12M	Buy	+34,237	New	+$1.34M	0.24%	107

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FORA Capital's BSX Position: Q1 2026 in Review

FORA Capital increased its Boston Scientific (BSX) stake by 3,044% in Q1 2026, buying an estimated $28.7M and bringing the position to 370,934 shares worth $23.3M. The position accounts for 1.71% of the portfolio, ranked #1.

FORA Capital first reported a position in BSX in Q1 2020 and has held it in 6 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

FORA Capital held 370,934 shares of Boston Scientific worth $23.3M as of Q1 2026.
FORA Capital bought 359,135 Boston Scientific shares in Q1 2026, an estimated $28.7M.
Boston Scientific made up 1.71% of FORA Capital's portfolio in Q1 2026, its #1 holding.
FORA Capital first reported a position in Boston Scientific in Q1 2020 and has held it in 6 quarters since.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.